GSK and CureVac restructure partnership in new licensing agreement | GSK

GSK acquires full rights to globally develop, manufacture and commercialize mRNA vaccine candidates for influenza and COVID-19, including combinations CureVac to receive €400 million upfront and up to €1.05 billion additional in development, regulatory and sales milestone payments, as well as tiered royalties; replacing all previous financial considerations from the prior collaboration agreement GSK plc … Read more

Volkswagen is so desperate that it is willing to pay $1 billion just to look at Rivian’s software

Volkswagen is desperate to see Rivian's software

Rivian and Volkswagen have announced a surprise partnership to develop next-generation software, electronic control units (ECUs) and related network architecture design and development. The move shows that Volkswagen’s gamble on Cariad has backfired, though Rivian’s software expertise may not have helped matters that much. As surprising as it may seem, the announced partnership between Rivian … Read more

Brussels is investigating antitrust investigation into Microsoft’s partnership with OpenAI

Unlock Editor’s Digest for free Roula Khalaf, editor-in-chief of the FT, selects her favorite stories in this weekly newsletter. Brussels is preparing for an antitrust investigation into Microsoft’s $13 billion investment in OpenAI, after the EU decided not to investigate a merger of the most powerful alliance in the artificial intelligence sector. The European Commission, … Read more